Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report.
Alessandro G FoisElisabetta SotgiuValentina ScanoSilvia NegriSabrina MellinoElisabetta ZinelluPietro PirinaGianfranco PintusCiriaco CarruArduino Aleksander MangoniAngelo ZinelluPublished in: Antioxidants (Basel, Switzerland) (2020)
pirfenidone and nintedanib exert beneficial effects on specific markers of oxidative stress and inflammation in IPF patients.